AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sage Group PLC

Regulatory Filings Mar 18, 2020

5322_rns_2020-03-18_e5db9f4e-ed0e-4225-b39a-6ae36823fc1c.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6586G

Sage Group PLC

18 March 2020

Suspension of share buy-back programme

18 March 2020

The Sage Group plc ("Sage") today announces that, in light of the current COVID-19 pandemic, it has decided to suspend its recently announced share buy-back programme, in order to preserve a high level of liquidity.

Sage has a strong balance sheet and low debt, supported by a resilient, recurring revenue stream and robust cash flow generation.  Whilst the impact of COVID-19 on Sage's business performance to date has been limited, the Board believes that given the highly uncertain economic outlook it is prudent to suspend the share buy-back.

The Board will consider restarting the share buy-back programme in due course.

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.  The person responsible for making this announcement on behalf of Sage is Vicki Bradin (Company Secretary).

Enquiries

The Sage Group plc  +44(0) 191 294 3457

Jonathan Howell, Chief Financial Officer

James Sandford, Investor Relations

Amy Lawson, Media

FTI Consulting  +44(0) 20 3727 1000

Charles Palmer

Dwight Burden

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCKKFBQNBKDPND

Talk to a Data Expert

Have a question? We'll get back to you promptly.